MedTech Week Magazine 2019 At a glance

Highlights from the 5th Edition of the Award-Winning MedTech Week Magazine

social white padded



I am particularly pleased to see so many examples of companies reaching out to their communities and engaging with employees – after all, medtech is really about people rather than technology.

Serge Bernasconi
Chief Executive, MedTech Europe
map box







twitter white


new fans & followers


website visits


video views

Bringing Sound & Vision to the message

Search MedTech Week magazine
Or filter articles & perspectives by tags
  • Patient
  • Expert
  • Value of medtech
  • Digital Health
  • Innovation
  • Career and education
  • Antimicrobial Resistance (AMR)
  • Regulations and legal
  • Cardiology
  • Orthopheadic
  • Homecare
  • Diagnostics
  • Diabetes


Perspectives New role for Clinical Research Organisations
Regulations and legal, Expert

New role for Clinical Research Organisations

Two new EU Regulations will require the collection and analysis of more data during clinical investigations

Perspectives Green is the new black
Value of medtech, Expert

Green is the new black

Climate action is rightfully gaining space on the policy agenda. Healthcare is part of the problem and must become part of the solution.

Perspectives Improving the lives of people living with diabetes
Diabetes, Expert

Improving the lives of people living with diabetes

It is incredible when I think that nearly 100 years have passed since the discovery of insulin. Since then, insulin has saved the lives of millions of people living with diabetes around the world.

Perspectives What do patients want
Diagnostics, Expert

What do patients want?

Patients don’t care about technology – they care about the quality of life

Perspectives Career inspiration My journey in biomedical engineering
Career and education, Expert

Career inspiration: My journey to biomedical engineering

At the age of seventeen, I was good at maths and sciences, but I did not know what to study after secondary school.

Perspectives Are you ready for Eudamed
Regulations and legal, Expert

Are you ready for Eudamed?

One of the biggest changes on the healthcare horizon will be new EU requirements for product information. If you are not already preparing for this, start now – the clock is ticking.

Perspectives Changing health changing lives
Value of medtech, Expert

Changing health, changing lives

Our sector has changed a great deal in the last decade, but there is much more innovation to come – notably in customisation and data.

Perspectives Incontinence  Breaking the taboo
Value of medtech, Expert

Incontinence: Breaking the taboo

The condition can be treated, often cured, and always managed

Perspectives Will it make the boat go faster
Value of medtech, Expert

‘Will it make the boat go faster?’

We need to work in partnership with healthcare providers to understand the true value of technologies.

Perspectives The future of medicine is personal
Value of medtech, Expert

The future of medicine is personal

We must all play our part in embedding personalised medicine into Europe’s healthcare systems

The future of medicine is personal

We must all play our part in embedding personalised medicine into Europe’s healthcare systems

Denis Horgan

Executive Director, European Alliance for Personalised Medicine

In the near future, healthcare services will increasingly deliver the right intervention to the right person at the right time, improving the outcomes for patients and cutting down unnecessary treatments.

Personalised medicine can also play a major role in prevention. Genome sequencing, for example, can identify patients at risk of developing disease, while state-of-the-art imaging, vaccinations and screening can reduce their risk of ill-health.

To ensure that this approach goes mainstream across the EU, there is a need for agreement on standards, and improvements to regulatory pathways, as well as an appropriate regulatory and medical framework.

Alongside this, given the reality that many common medicines are not effective in treating large numbers of the patients they are supposed to help, personalised medicine offers a promising alternative.

This tailor-made treatment strategies for individuals or groups of individuals permit patients to receive the specific therapies that work best for them, eliminating waste on trial and error.

Unfortunately, at present, regulatory and reimbursement systems are not adapted to respond to the new opportunities that these novel therapeutics offer.

Greater understanding could help unleash waves of new medicines that would improve patients' lives, and transform society's approach to healthcare. For EU policymakers and healthcare stakeholder, this is our shared task for the next five years – we must rise to occasion to accelerate the adoption of personalised care.

Medtech Week magazine archive

Click on the covers to view full magazine online